within Pharmacolibrary.Drugs.ATC.C;

model C01CA16
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.2,
    Cl             = 25 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 0.044,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Ibopamine is a dopamine analogue and a prodrug that is metabolized to epinine. It was used as a vasodilator and positive inotropic agent for the management of heart failure and low cardiac output states. Ibopamine is not widely approved or used in current clinical practice.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic profile based on class analogy and available reviews, as no direct human PK data for ibopamine exist in accessible literature.</p><h4>References</h4><ol><li><p>Itoh, H (1991). Clinical pharmacology of ibopamine. <i>The American journal of medicine</i> 90(5B) 36S–42S. DOI:<a href=&quot;https://doi.org/10.1016/0002-9343(91)90272-y&quot;>10.1016/0002-9343(91)90272-y</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1675550/&quot;>https://pubmed.ncbi.nlm.nih.gov/1675550</a></p></li><li><p>de Mey, C, et al., &amp; Wesche, H (1988). Pharmacokinetics and pharmacodynamics of single oral doses of ibopamine, quinidine and their combination in normal man. <i>European journal of clinical pharmacology</i> 34(4) 415–418. DOI:<a href=&quot;https://doi.org/10.1007/BF00542446&quot;>10.1007/BF00542446</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3402527/&quot;>https://pubmed.ncbi.nlm.nih.gov/3402527</a></p></li><li><p>Ogawa, R, et al., &amp; Echizen, H (2014). Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 2, drugs administered orally). <i>Clinical pharmacokinetics</i> 53(12) 1083–1114. DOI:<a href=&quot;https://doi.org/10.1007/s40262-014-0189-3&quot;>10.1007/s40262-014-0189-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25248847/&quot;>https://pubmed.ncbi.nlm.nih.gov/25248847</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C01CA16;
